Similar articles

• [The therapeutic position of nedocromil sodium (Tilade) in the treatment of bronchial asthma].

  Mihălţan F, Ulmeanu R, Panghea P. Mihălţan F, et al. Pneumologia. 1999 Oct-Dec;48(4):309-12. Pneumologia. 1999. PMID: 10856993 Review. Romanian. No abstract available.
• Population pharmacokinetic and pharmacodynamic analysis in allergic diseases.

  Lovern M, Sargentini-Maier ML, Otoul C, Watelet JB. Lovern M, et al. Drug Metab Rev. 2009;41(3):475-85. doi: 10.1080/10837450902891543. Drug Metab Rev. 2009. PMID: 19601723
• L-Carnitine ester of prednisolone: pharmacokinetic and pharmacodynamic evaluation of a type I prodrug.

  Mo J, Lim LY, Zhang ZR. Mo J, et al. Int J Pharm. 2014 Nov 20;475(1-2):123-9. doi: 10.1016/j.ijpharm.2014.08.049. Epub 2014 Aug 27. Int J Pharm. 2014. PMID: 25173636
• Fluticasone and asthma.

  Edsbäcker S, Thorsson L. Edsbäcker S, et al. Lancet. 2001 Mar 10;357(9258):804. doi: 10.1016/S0140-6736(05)71231-9. Lancet. 2001. PMID: 11253999 No abstract available.
• Biopharmaceutical therapeutics for asthma remodeling.

  Das AM, Griswold DE, Torphy TJ, Li L. Das AM, et al. Curr Pharm Des. 2006;12(25):3233-40. doi: 10.2174/138161206778194097. Curr Pharm Des. 2006. PMID: 17020531 Review.